The Prescription: 17th January 2018 Issue
Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive
EDITOR'S EMULSION

Pooja Khaitan

Greetings!

With holidays over and most of us back on our desk, it’s time to take things a little more seriously now. Hazards in the health sector are innumerable, be it ‘cause of unsafe meds or diagnostic issues. In healthcare, a brand needs to be 100% honest with their customers. While Pharma companies should be pro active towards the quality and replication of their drugs in the market, Diagnostic companies should offer accessible, affordable services while ensuring accuracy. What is worse is that the curse of wrong diagnosis is very difficult to break. Incorrect diagnosis will lead to inaccurate treatment, resulting in prolonged treatment, leading to complications due to wrong medicines, and the burden of unwanted expenses. In this issue of PSM India Capsules we throw some light on how to find the right diagnosis for you.

There comes some good news from the government in the first month of this year. To ensure better systems and frameworks for the healthcare workforce in the country the Ministry has launched the Allied and Healthcare Professionals’ database portal. In Drug laws and Policy Injections, read more on this and also on inspections of drug testing labs in our country commencing after over a decade.
Read More>>>

Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@safemedicinesindia.in

The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions remains to be seen. Post your pics on our facebook wall or chirp it on our twitter handle. Go ahead and reach out.

Stay Healthy. Stay Protected.

Pooja Khaitan

Editor-in-Chief,
The Prescription

DOSE OF THE DAY

“National Health Policy" marks a historic moment in our endeavour to create a healthy India where everyone has access to quality healthcare.”

Hon’ble Prime Minister, Shri Narendra Modi

FB Tw SUBSCRIBE
PSM India Capsules

Are You Being Diagnosed Correctly?

When it comes to medical care, no one wants to compromise. Everyone wants to avail the best possible facilities as per their capacity. But in an era where medical expenses and complications are mounting with each passing day and news of malpractices by even the best names in the industry have become an almost daily affair, the customer should be aware of the various possibilities of malpractices in the diagnostic process also. After all, correct diagnosis is the first step towards correct treatment.
In healthcare, a brand needs to be 100% honest with their customers. Diagnostic companies should offer accessible, affordable services while ensuring accuracy. What is worse is that the curse of wrong diagnosis is very difficult to break. Incorrect diagnosis will lead to inaccurate treatment, resulting in prolonged treatment, leading to complications due to wrong medicines, and the burden of unwanted expenses.

Read More
Drug Laws & Policy Injections
DCGI Starts Inspections Of Drug Testing Labs In Country After A Gap Of Over A Decade Mumbai, Jan 2018: Drug Controller General of India (DCGI) has started conducting joint inspections of drug testing labs across the country with respective state drug controllers after a gap of over a decade. DCGI had earlier alerted the drug testing labs to verify and assess their compliance levels through a self- audit to ensure audit -readiness before an inspection.Read More
MoH To Usher In PvPI Skill Development From Jan 15 To Produce Qualified PV Personnel For AMCs Mumbai, Jan 2018: As a step towards producing skilled workforce to further strengthen pharmaco-vigilance (PV) in India, around 50 healthcare professionals will be trained every alternate month under the guidance of Indian Pharmacopoeia Commission (IPC), which is the national coordination center (NCC) for Pharmacovigilance Programme of India (PvPI) under the union health ministry from January 15, 2018 onwards.Read More
Health Secretary Launches The Allied Health Professionals Database PortalNew Delhi, January 2018: Ms. Preeti Sudan, Secretary, Health and Family Welfare launched the Allied and Healthcare Professionals’ database portal, as part of Ministry’s commitment to ensure better systems and frameworks for the healthcare workforce in the country. Read More
National Medical Commission Bill Sent To Standing CommitteeNew Delhi, Jan 2018: The National Medical Commission Bill, 2017, which seeks to replace the Medical Council of India with a new body, was referred to the Parliamentary Standing Committee. More than 2.9 lakh doctors had gone on a 12-hour nationwide strike (6 a.m. to 6 p.m.) in protest against the Bill, which seeks to allow those practicing alternative and traditional medicine to practice allopathy after completing a "bridge course". Read More
No Plans To Revamp NPPA: GovtNew Delhi, Jan 2018: The government is not considering revamping the drug price regulator NPPA or setting up an advisory body above it, Parliament was informed today. In a written reply to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the government is not revamping the NPPA. Read More
Pharma Injections
Plan To Make Uttar Pradesh A Hub Of Pharma SectorLucknow, Jan 2018: The state government is more than willing to extend all support to the pharmaceutical sector to make UP a hub of pharma industries like Himachal Pradesh and Gujarat. Tax rebate, subsidy on interest on loan availed to set up pharma industry in proposed pharma parks, plots for setting up units and lower electricity traffic have been finalised for the pharmaceutical sector.Read More
Indian R & D Based Pharma Companies Get 304 ANDA Approvals In 2017Mumbai, Jan 2018: Indian pharmaceutical companies and their subsidiaries received 304 final ANDA approvals from US FDA during 2017 as compared to 201 ANDA approvals in the previous year. The US FDA approved total 846 ANDA during 2017 which remained highest during last decade. Indian companies with enhanced R&D investments during last couple of years, managed to secure almost 36 per cent of total approvals by US FDA. Further, US FDA approved 171 tentative approvals and out of this Indian companies grab 61 tentative approvals in 2017. Higher rate of approvals for Indian companies will translate into higher revenues in near future.Read More
Court Directs Pharma Company To Donate Seized Drugs To Government-Run Hospitals Mumbai, Jan 2018: In a one of its kind order, a civil court in Navi Mumbai has directed a Haryana-based pharma company to donate seized Ayurvedic drugs worth Rs 28 lakh to government-run hospitals. The court has also slapped a fine of Rs 10,000 on the company for violating the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. The court’s ruling comes in response to the prosecution initiated by State Food and Drugs Administration (FDA). The regulatory authority had seized a stock of the company for wrongful advertisement. Read More
Dip In Pharma Exports Due To Shifting Of Manufacturing Bases, Market Consolidation NEW DELHI, JAN 2018: Shifting of manufacturing bases to overseas markets by certain domestic companies and absence of blockbuster drugs going off-patent are some of reasons for dip in India's pharmaceutical exports. In 2016-17, the exports decreased by 0.43 per cent in value terms and 6.95 per cent in volume terms, Minister of State for Commerce and Industry C R Chaudhary said in a written reply to a Unstarred Question No. 1776 in the Rajya Sabha. Read More
CCI Slaps Fine On Two Gujarat Chemists Associations New Delhi, Jan 2018: Clamping down on unfair trade practices in pharma business, the Competition Commission has imposed a total penalty of over ₹ 12 lakh on two Gujarat- based chemists groupings. The two associations are Chemists and Druggists Association of Baroda (CDAB) and Federation of Gujarat State Chemists & Druggists Association. The Competition Commission of India (CCI), which has been making efforts to sensitise the public on unfair ways in the pharma industry, has also asked the two associations and their respective office bearers to cease and desist from indulging in anti-competitive practices. Read More
NITI Aayog May Revamp Process Of Drug Selection For Price Control New Delhi, Jan 2018: New Delhi, 9 Jan 2018: Government think tank NITI Aayog is working to revamp the existing system of identifying medicines for price control, two persons aware of the matter said. Read More
Drug Dopes
Updated LIST OF NEW DRUGS APPROVED FROM 01-01-2017 TILL DATE BY NEW DRUGS DIVISION, CDSCO, FDA Bhawan, New Delhi List of New Drug Approved by FDA Read More
DCGI Bans Import Of Drug Ingredients From Six Chinese FirmsNew Delhi, Jan 2018: Citing quality issues, India’s drug regulator Drug Controller General of India (DCGI) has banned the import of ingredients of drugs from six major Chinese pharmaceutical firms. Read More
FIR On Drug Shop Owner After RaidsPatna, Jan 2018: The state drug control administration on Saturday lodged FIR against four people in connection with a raid at the Machhua Toli-based Medicine Pharmaceuticals for manufacturing medicines under the label of Rathi Laboratory in Patna and also selling banned medicines. Read More
3 Firms May Face Action For Selling Hypertension Drug Without Approval New Delhi, Jan 2018: The Drug Controller General of India (DCGI) may initiate legal action against three local drug makers for selling a combination drug to treat hypertension without mandatory prior approval. Read More
India Imposes Antidumping Duty On 98 Products From China New Delhi, Jan 2018 (PTI): India has imposed antidumping duty on as many as 98 products, as on December 27 last year, ,The products on which the duty was imposed include flax fabrics, vitamin C, Paracetamol, Vitamin –A Palmitate-II, Ceftriaxone Sodium Sterile, Diclofenac Sodium, Gliclazide, Albendazole, certain fibres and chemicals, Minister of State for Commerce and Industry C R Chaudhary said in a written reply to Rajya Sabha. Read More
Sub-Standard Medicines Supplied To Govt. Hospitals New Delhi, Jan 2018: Leader of Opposition in the Delhi Vidhan Sabha, Vijender Gupta, on Saturday raised questions against the Aam Aadmi Party (AAP) Delhi government over the matter of alleged supply of sub-standard medicines to hospitals and dispensaries under its jurisdiction. Read More
National Injections
Government Trashes WHO Report Pointing To 57% Fake Doctors New Delhi, Jan 2018: The government today termed as "erroneous" a World Health Organisation (WHO) report titled "The Health Workforce in India" which claimed that 57 per cent of allopathic doctors in India do not have medical qualification. Read More
Odisha: Girl Taking Expired Tuberculosis Drugs SuccumbsCUTTACK, JAN 2018: Gudi Naik, whose condition had worsened after consuming expired TB medicine for more than three months, succumbed while undergoing treatment at SCB Medical College and Hospital here on Sunday morning. She was admitted to the hospital on Saturday.Read More
Bhopal: Cancer Patient Given 'Expired' Drugs At Lake City Hospital Bhopal, Jan 2018: In case of blatant negligence, a cancer patient at Lake City Hospital, Kasturba Nagar was administered an expired medicine on intervening night of Tuesday and Wednesday. The medicine was purchased from the medical shop at the hospital. The patient is however doing fine and is stable. A cancer patient, Awadhram Yadav was admitted to the hospitals Intensive Care Unit on December 27 for lungs infection. Yadav, who has tongue cancer, belongs to a rural area of Seoni district. Read More
Bacteria Wall For Antibiotics: 75% Culture Tests In Hyderabad Fail HYDERABAD, JAN 2018: Antibiotic resistance has assumed alarming proportions in Hyderabad with diagnostic laboratory culture tests failing to yield result. City doctors said, bacteria are unable to grow in culture medium as it developed resistance. A research study revealed 75% urine culture tests analysed failed to give results. This will have a severe impact on diagnostic results as patients suffering from health issues like urinary tract infection may get a negative result though they harbour relevant bacteria in their bodies. Read More
40 Complaints Regarding Stent Overpricing Received New Delhi, Jan 2018 (PTI): Drug pricing regulator NPPA has received a total of 40 complaints so far for overpricing of coronary stents by hospitals, Parliament was informed today. Read More
HCFI Calls For Cancer Drugs To Be Under Price Control To Make It Affordable For Masses Mumbai, Jan 2018: Although cancer has become like an epidemic with a steep rise in its incidence, the cancer medicines are very expensive and beyond the reach of common man. Therefore, government should bring price control on all cancer drugs to make them affordable to people, said Dr K K Aggarwal, president of Heart Care Foundation of India (HCFI). Read More
Global Injections
Near Half Nepali Drugs Manufacturers Operate Illegally KATHMANDU, JAN 2018: Twenty-five domestic drugs manufacturers have been operating illegally. However, the Department of Drug Administration (DDA) has not taken any action. Read More
New US Drug Approvals Hit 21-Year High In 2017 LONDON, JAN 2018 (Reuters): U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union. Read More

US FDA Issues Draft Guidance For Industry, Good ANDA Submission Practices, And Companion MAPP, Good ANDA Assessment Practices Maryland, Jan 2018: Today, the FDA issued the draft guidance for industry “Good ANDA Submission Practices,” which highlights common, recurring deficiencies in abbreviated new drug applications (ANDAs) that may lead to a delay in the approval of an ANDA.Read More

3 held for importing, marketing fake drugs Bangladesh: Members of Criminal Investigation Department (CID) arrested three persons for their alleged involvement with importing fake cancer-fighting medicines from China and marketing those in the country, reports BSS. “We arrested Ruhul Amin alias Dulal Chowdhury, 46, Nikhil Raj Bongshi, 44, and Sayeed and recovered around 21,000 strips of fake medicine including medicine MT-X, Clomid and Revocon.Read More

PSM PILL

U.S. Postal Inspectors Are On The Front Line In The Fight To Keep Fentanyl Out Of The Country

According to the Washington Post, U.S. Postal Inspectors are increasingly finding themselves on the front line in the fight to keep fentanyl out of the country. When South Dakota resident Trevor Harden ordered thousands of fentanyl pills off the internet, a package containing part of his shipment caught the eye of postal inspectors in Rapid City, South Dakota. Authorities were alerted and were waiting when Harden picked up his package.

Read More

Report: Counterfeit Medications Containing Deadly Fentanyl Have Been Found In 40 States

WASHINGTON (BUSINESS WIRE): A newly-released report on counterfeit medicines is placing the spotlight on a problem that may be far worse than is commonly believed. According to the review conducted by The Partnership for Safe Medicines, counterfeit prescription drugs containing the deadly ingredient fentanyl, most often illegally imported, have been found in as many as 40 states and are tied to deaths in more than a dozen states.

Read More

Frequently Asked Questions Q1. What is Family Medicine?
Answer: Family medicine (FM), formerly family practice (FP), is a specialty devoted to comprehensive health care for people of all ages; the specialist is named a family physician or family doctor. In Europe the discipline is often referred to as general practice and a practitioner as a General Practice Doctor or GP; this name emphasises the holistic nature of this speciality, as well as its roots in the family. Family practice is a division of primary care that provides continuing and comprehensive health care for the individual and family across all ages, genders, diseases, and parts of the body;family physicians are often primary care physicians. It is based on knowledge of the patient in the context of the family and the community, emphasizing disease prevention and health promotion.According to the World Organization of Family Doctors (WONCA), the aim of family medicine is to provide personal, comprehensive, and continuing care for the individual in the context of the family and the community. The issues of values underlying this practice are usually known as primary care ethics.

Q2.What makes family medicine unique?
Answer: Family medicine's cornerstone is an ongoing, personal patient–physician relationship. Whereas other specialties are limited to a particular organ system, technology, disease, age, or sex, family medicine integrates care for each person. Family physicians' unique contributions to health care access stem from the breadth of their training and adaptability of their work, combined with a sense of social responsibility.
Patients value a physician who listens to them, who takes time to explain things to them, and who is able to effectively coordinate and integrate their care.4 Since its inception, family medicine has been grounded in the core values of a continuing relationship between patient and physician, and the provision of comprehensive care that includes prevention, acute intervention, chronic disease management, end-of-life care, and coordination of care throughout the health care delivery system

SUBSCRIBER'S SYMPTOM

There Can't Be Different Standards For Private and Government Hospitals

Article contributed by an Aware homemaker: Ms. Sushila Bajpai from Madhya Pradesh

The Delhi High Court on 4th January 2018 said the Centre and the AAP government cannot have different standards for private hospitals and those run by them as far as instances of medical negligence are concerned. The observation by Justice Vibhu Bakhru came during the hearing of a plea alleging medical negligence by Safdarjung Hospital in wrongly declaring a newborn as dead in June 2017. Read More

Upcoming Events
UpComing Events
Click Here For More Events
Laughter Dose
Blog Addicts
Ms. Vaani Manchandaa, Pharma Academician: Thank you PSM India Initiative. Continue the good work!
Dr. Naresh Kumar, Research Scholar: PSM India is at all times trying to keep us up-to-date with the latest medication news, fake drug news and approvals which is indeed praiseworthy!
Dr. S. Chakravarty, Principal of a reputed Pharma and allied Health Sciences Institution: My earnest gratitude and applauds to PSM-India for the continuous action they have taken in fighting menace of unsafe medicines and their advocacy in assuring universal healthcare for all in India!
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048
www.safemedicinesindia.in; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.